This inventor holds 9 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Conagen Inc.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: The Innovative Journey of Michael Batten in Biotechnology
Introduction
Michael Batten is a talented inventor based in Westford, Massachusetts, known for his significant contributions to the field of biotechnology. With a remarkable portfolio of eight patents, he has made strides in the production of steviol glycosides, which have applications in various industries, including food and pharmaceuticals.
Latest Patents
Two of his latest patents showcase his expertise in biosynthetic processes. The first patent, titled "Biosynthetic production of steviol glycosides and processes therefore," focuses on the production of steviol glycoside rebaudiosides D4, WB1, WB2, and the creation of rebaudioside M from Reb D4. This innovative approach has the potential to enhance the efficiency of glycoside production.
The second patent, "Biosynthetic production of steviol glycoside rebaudioside I via variant enzymes," details a methodology for producing rebaudioside I using variant UGT enzymes. This process involves transferring a glucosyl group from UDP-glucose to rebaudioside A, highlighting his innovative use of enzyme technology.
Career Highlights
Michael Batten is currently employed at Conagen Inc., a leading company in biotechnology. His work has positioned him as a notable figure in the industry, contributing to various advancements in natural product synthesis. His extensive knowledge and experience have helped lead to multiple patented technologies that promote sustainable and efficient practices in biochemical production.
Collaborations
Throughout his career, Michael has worked alongside talented colleagues, including Guohong Mao and Jacob Edward Vick. These collaborations reflect a strong team dynamic at Conagen Inc., where innovation thrives through collective expertise and shared objectives.
Conclusion
Michael Batten continues to be a driving force in the field of biotechnology. His dedication to developing innovative processes for the production of steviol glycosides demonstrates his commitment to enhancing sustainability in the industry. As he advances his research and development efforts, we look forward to seeing the future impacts of his inventions on our lives and the environment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile